{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T15:10:23Z","timestamp":1776179423557,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.dsx.2021.03.027","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T05:44:55Z","timestamp":1617255895000},"page":"777-782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Dipeptidyl peptidase-4 (DPP-4) inhibitor and mortality in coronavirus disease 2019 (COVID-19) \u2013 A systematic review, meta-analysis, and meta-regression"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3612-4446","authenticated-orcid":false,"given":"Iis Inayati","family":"Rakhmat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4202-4038","authenticated-orcid":false,"given":"Yudith Yunia","family":"Kusmala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4135-0248","authenticated-orcid":false,"given":"Dewi Ratih","family":"Handayani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2544-9037","authenticated-orcid":false,"given":"Henny","family":"Juliastuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8569-5504","authenticated-orcid":false,"given":"Eka Noneng","family":"Nawangsih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arief","family":"Wibowo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Anthonius","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3998-6551","authenticated-orcid":false,"given":"Raymond","family":"Pranata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2021.03.027_bib1","series-title":"Weekly epidemiological update - 9 February 2021","author":"World Health Organization","year":"2021"},{"key":"10.1016\/j.dsx.2021.03.027_bib2","article-title":"Multiorgan failure with emphasis on acute kidney injury and severity of COVID-19: systematic review and meta-analysis","volume":"7","author":"Lim","year":"2020","journal-title":"Can J Kidney Heal Dis"},{"key":"10.1016\/j.dsx.2021.03.027_bib3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.dsx.2020.04.018","article-title":"Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia \u2013 a systematic review, meta-analysis, and meta-regression: diabetes and COVID-19","volume":"14","author":"Huang","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.dsx.2021.03.027_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3330","article-title":"DPP4 inhibition: preventing SARS-CoV-2 infection and\/or progression of COVID-19?","volume":"36","author":"Strollo","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.dsx.2021.03.027_bib5","doi-asserted-by":"crossref","first-page":"108125","DOI":"10.1016\/j.diabres.2020.108125","article-title":"COVID-19 and diabetes: can DPP4 inhibition play a role?","volume":"162","author":"Iacobellis","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.dsx.2021.03.027_bib6","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3389\/fphar.2020.01161","article-title":"DPP4 and ACE2 in diabetes and COVID-19: therapeutic targets for cardiovascular complications?","volume":"11","author":"Valencia","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.dsx.2021.03.027_bib7","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.2337\/dc20-1521","article-title":"Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and covid-19: a multicenter case-control retrospective observational study","volume":"43","author":"Solerte","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2021.03.027_bib8","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2337\/dc20-0660","article-title":"Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication","volume":"43","author":"Chen","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2021.03.027_bib9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.numecd.2020.09.028","article-title":"Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily","volume":"31","author":"Silverii","year":"2021","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.dsx.2021.03.027_bib10","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.2337\/dc20-1340","article-title":"Impact of comorbidities and glycemia at admission and dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes with covid-19: a case series from an academic hospital in lombardy, Italy","volume":"43","author":"Mirani","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2021.03.027_bib11","doi-asserted-by":"crossref","DOI":"10.2337\/dc20-1824","article-title":"Association between DPP-4 inhibitors and COVID-19 related outcomes among patients with type 2 diabetes","author":"Noh","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2021.03.027_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-020-01832-2","article-title":"Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study","volume":"18","author":"P\u00e9rez-Belmonte","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.dsx.2021.03.027_bib13","first-page":"1","article-title":"Use of Dipeptidyl Peptidase-4 inhibitors and prognosis of COVID -19 in hospitalized patients with type 2 diabetes: a propensity score analysis from the CORONADO study","author":"Roussel","year":"2021","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.dsx.2021.03.027_bib14","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.12998\/wjcc.v8.i22.5576","article-title":"No significant association between dipeptidyl peptidase-4 inhibitors and adverse outcomes of COVID-19","volume":"8","author":"Zhou","year":"2020","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.dsx.2021.03.027_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/dom.14097","article-title":"Exposure to dipeptidyl-peptidase-4 inhibitors and COVID-19 among people with type 2 diabetes: a case-control study","volume":"22","author":"Fadini","year":"2020","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.dsx.2021.03.027_bib16","doi-asserted-by":"crossref","first-page":"602","DOI":"10.4093\/dmj.2020.0146","article-title":"The clinical characteristics and outcomes of patients with moderate-to-severe coronavirus disease 2019 infection and diabetes in Daegu, South Korea","volume":"44","author":"Kim","year":"2020","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.dsx.2021.03.027_bib17","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.dsx.2020.11.006","article-title":"The effect of metformin consumption on mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis","volume":"14","author":"Lukito","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.dsx.2021.03.027_bib18","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.dsx.2020.06.047","article-title":"The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis","volume":"14","author":"Pranata","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.dsx.2021.03.027_bib19","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00592-020-01539-z","article-title":"Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19","volume":"57","author":"Solerte","year":"2020","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.dsx.2021.03.027_bib20","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/22221751.2020.1739565","article-title":"Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26","volume":"9","author":"Vankadari","year":"2020","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.dsx.2021.03.027_bib21","first-page":"649","article-title":"COVID-19 and comorbidities: a role for dipeptidyl peptidase 4 (DPP4) in disease severity?","volume":"12","author":"Bassendine","year":"2020","journal-title":"J\u00a0Diabetes"},{"key":"10.1016\/j.dsx.2021.03.027_bib22","article-title":"Multiorgan failure with emphasis on acute kidney injury and severity of COVID-19: systematic review and meta-analysis","volume":"7","author":"Lim","year":"2020","journal-title":"Can J Kidney Heal Dis"},{"key":"10.1016\/j.dsx.2021.03.027_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/1753466620937175","article-title":"C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis","volume":"14","author":"Huang","year":"2020","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.dsx.2021.03.027_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2020.11.011","article-title":"Elevated interleukin levels are associated with higher severity and mortality in COVID 19 \u2013 a systematic review, meta-analysis, and meta-regression","author":"Yonas","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.dsx.2021.03.027_bib25","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.dsx.2020.06.050","article-title":"A\u00a0wave of non-communicable diseases following the COVID-19 pandemic","volume":"14","author":"Lim","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.dsx.2021.03.027_bib26","article-title":"Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta-analysis and meta-regression","volume":"21","author":"Pranata","year":"2020","journal-title":"JRAAS - J Renin-Angiotensin-Aldosterone Syst"},{"key":"10.1016\/j.dsx.2021.03.027_bib27","doi-asserted-by":"crossref","first-page":"104949","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104949","article-title":"Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19 \u2013 systematic review, meta-analysis, and meta-regression","author":"Pranata","year":"2020","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.dsx.2021.03.027_bib28","doi-asserted-by":"crossref","DOI":"10.1177\/1179548420959165","article-title":"The association between chronic kidney disease and new onset renal replacement therapy on the outcome of COVID-19 patients: a meta-analysis","volume":"14","author":"Pranata","year":"2020","journal-title":"Clin Med Insights Circulatory, Respir Pulm Med"},{"key":"10.1016\/j.dsx.2021.03.027_bib29","first-page":"1","article-title":"Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19","volume":"24","author":"Pranata","year":"2020","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.dsx.2021.03.027_bib30","article-title":"Body mass index and outcome in patients with COVID-19: a dose-response meta-analysis","author":"Pranata","year":"2020","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.dsx.2021.03.027_bib31","doi-asserted-by":"crossref","first-page":"104324","DOI":"10.1016\/j.archger.2020.104324","article-title":"Clinical frailty scale and mortality in COVID-19: a systematic review and dose-response meta-analysis: clinical Frailty Scale in COVID-19","volume":"93","author":"Pranata","year":"2021","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.dsx.2021.03.027_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2020.06.047","article-title":"The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis","author":"Pranata","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402121001016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402121001016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:14:10Z","timestamp":1761729250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402121001016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1871402121001016"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2021.03.027","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dipeptidyl peptidase-4 (DPP-4) inhibitor and mortality in coronavirus disease 2019 (COVID-19) \u2013 A systematic review, meta-analysis, and meta-regression","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2021.03.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}